Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Joly

Showing results (171-180 of 227) with videos related to

Pageof 23
Sort By:
The Journal of Investigative Dermatology|August 24, 2007
Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case-control studyPascal Joly, Cloe Benoit-Corven, Sophie Baricault, et al.
Clinical and Experimental Dermatology|July 6, 2023
Clinical features, therapeutic choice and response by phototype in psoriasis: analysis of the French PsoBioTeq cohortRomain Salle, Florence Tubach, Hugo Arlegui, et al.
European Journal of Human Genetics : EJHG|January 20, 2012
Novel and recurrent non-truncating mutations of the MITF basic domain: genotypic and phenotypic variations in Waardenburg and Tietz syndromesSandy Léger, Xavier Balguerie, Alice Goldenberg, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 27, 2010
Juvenile psoriasis and its clinical management: a European expert group consensusMona Ståhle, Nilgun Atakan, Wolf-Henning Boehncke, et al.
JAMA Dermatology|March 17, 2021
Mixed Individual-Aggregate Data on All-Cause Mortality in Bullous Pemphigoid: A Meta-analysisBillal Tedbirt, André Gillibert, Emilie Andrieu, et al.
Chest|June 20, 2014
A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosisCatherine Droitcourt, Michel Rybojad, Raphaël Porcher, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2024
Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare databaseLaurent Mortier, Astrid Blom, Benoît van Hille, et al.
Blood|January 17, 2004
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomasFlorent Grange, Tony Petrella, Marie Beylot-Barry, et al.
Archives of Dermatology|September 19, 2007
Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 casesFlorent Grange, Marie Beylot-Barry, Phillipe Courville, et al.
The British Journal of Dermatology|June 6, 2022
Granulomatous slack skin: clinical characteristics, prognosis and response to therapy. A study from the Cutaneous Lymphoma French Study GroupGilles Battesti, Caroline Ram-Wolff, Gabor Dobos, et al.
Pageof 23

Showing results (171-180 of 227) with videos related to

Sort By:
Pageof 23
The Journal of Investigative Dermatology|August 24, 2007
Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case-control studyPascal Joly, Cloe Benoit-Corven, Sophie Baricault, et al.
Clinical and Experimental Dermatology|July 6, 2023
Clinical features, therapeutic choice and response by phototype in psoriasis: analysis of the French PsoBioTeq cohortRomain Salle, Florence Tubach, Hugo Arlegui, et al.
European Journal of Human Genetics : EJHG|January 20, 2012
Novel and recurrent non-truncating mutations of the MITF basic domain: genotypic and phenotypic variations in Waardenburg and Tietz syndromesSandy Léger, Xavier Balguerie, Alice Goldenberg, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 27, 2010
Juvenile psoriasis and its clinical management: a European expert group consensusMona Ståhle, Nilgun Atakan, Wolf-Henning Boehncke, et al.
JAMA Dermatology|March 17, 2021
Mixed Individual-Aggregate Data on All-Cause Mortality in Bullous Pemphigoid: A Meta-analysisBillal Tedbirt, André Gillibert, Emilie Andrieu, et al.
Chest|June 20, 2014
A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosisCatherine Droitcourt, Michel Rybojad, Raphaël Porcher, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2024
Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare databaseLaurent Mortier, Astrid Blom, Benoît van Hille, et al.
Blood|January 17, 2004
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomasFlorent Grange, Tony Petrella, Marie Beylot-Barry, et al.
Archives of Dermatology|September 19, 2007
Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 casesFlorent Grange, Marie Beylot-Barry, Phillipe Courville, et al.
The British Journal of Dermatology|June 6, 2022
Granulomatous slack skin: clinical characteristics, prognosis and response to therapy. A study from the Cutaneous Lymphoma French Study GroupGilles Battesti, Caroline Ram-Wolff, Gabor Dobos, et al.
Pageof 23